Showing 173,621 - 173,640 results of 261,435 for search '(( 0 ((0 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 3.01s Refine Results
  1. 173621
  2. 173622
  3. 173623
  4. 173624
  5. 173625
  6. 173626
  7. 173627
  8. 173628

    Data_Sheet_1_Sex difference and outcome trends following transcatheter aortic valve replacement.docx by Gabby Elbaz-Greener (11005926)

    Published 2022
    “…Differences in mortality rates among sexes were observed, presenting with higher in-hospital mortality in women than in men, OR 1.26 [95% CI 1.18–1.35], p < 0.001.</p>Conclusion<p>Utilization of TAVR demonstrated a steady upward trend during 2011–2017, and a similar trend was presented for both sexes. …”
  9. 173629

    Loss of pancreatic cell identity in <i>Pdx1-Cre; Ctnnb1</i><sup><i>tm1Mmt/+</i></sup> pancreas. by Jose Luis Muñoz-Bravo (3220134)

    Published 2016
    “…Data are presented as mean ± SEM; * p < 0.05 (Student's <i>t</i>-test). Scale bars 100 μm, (in A for A-B; in E for E-H; in I for I-J).…”
  10. 173630

    dataset.zip by Guo Bin (3537743)

    Published 2016
    “…In this study, pooled and within-subtypes analysis was performed by using a cluster level threshold of 0.05, a permutation threshold of 1000, and a FDR-corrected P value of less than 0.05. …”
  11. 173631

    Data_Sheet_1_Impact of home-based training and nutritional behavior on body composition and metabolic markers in cancer patients: data from the CRBP-TS study.docx by Sophia Darmochwal (17004918)

    Published 2023
    “…</p>Results<p>The intervention group's fat mass decreased while their lean body mass increased (time effect p = 0.001 and p = 0.001, respectively). …”
  12. 173632

    Supplementary Material for: Impact of Abemaciclib-induced Serum Creatinine Elevation on Dose Adjustment of Concomitant Medications by figshare admin karger (2628495)

    Published 2025
    “…After ABE discontinuation, CCr values returned to baseline levels. Overall, 50.2% of patients experienced a change in renal function classification after ABE initiation (P < 0.01), and 22.6% required dose adjustment owing to these changes. …”
  13. 173633

    Figure 5 by Thomas B. Nicholson (406800)

    Published 2013
    “…(A) Lsd1 mRNA levels were decreased by approximately 50%, confirming the microarray data. …”
  14. 173634

    Double fluorescence study by flow cytometry of CD45RO lymphocytes subpopulations and apoptosis by CD8<sup>+</sup>CD25<sup>+</sup> regulatory T cells during IVMP. by Yi-Giien Tsai (514981)

    Published 2014
    “…(*<sup>#</sup><i>p</i><0.05). (c). siRNA of FoxP3 decreased granzyme B protein expression in CD8<sup>+</sup>CD25<sup>+</sup> Treg cells if pretreated with nucleosomal histone peptide epitope (H3:115–135) and dexamethasme (50 nM). …”
  15. 173635
  16. 173636
  17. 173637

    Data from: Can manure application method and timing with cover crops reduce ammonia (NH3) and nitrous oxide (N2O) gas losses and sustain corn yield? by Sailesh Sigdel (22062727)

    Published 2025
    “…Compared to BM LATE, BM EARLY reduced NH3 loss 43%, increased CC N, reduced N2O emission 50%, but decreased corn yield 11%. When IM was EARLY compared to LATE, CC N increased 84%, cumulative N2O loss decreased 55%, and corn yield was similar. …”
  18. 173638
  19. 173639

    DataSheet1_SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.zip by Ruixue Guo (6377939)

    Published 2022
    “…Additionally, SGLT2, IGF1R, phosphorylated PI3K, α-SMA, SNAI-1, and ZEB2 protein levels were increased in high glucose-stimulated human podocytes (HPC) and significantly decreased in dapagliflozin-treated (50 nM and 100 nM) or OSI-906-treated (inhibitor of IGF1R, 60 nM) groups. …”
  20. 173640

    Image4_SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.TIF by Ruixue Guo (6377939)

    Published 2022
    “…Additionally, SGLT2, IGF1R, phosphorylated PI3K, α-SMA, SNAI-1, and ZEB2 protein levels were increased in high glucose-stimulated human podocytes (HPC) and significantly decreased in dapagliflozin-treated (50 nM and 100 nM) or OSI-906-treated (inhibitor of IGF1R, 60 nM) groups. …”